Tg Therapeutics reported $95.27M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Arrowhead Research ARWR:US $ 110.25M 19.49M
Bayer BAYN:GR 9.1B 154M
Corcept Therapeutics CORT:US $ 62.16M 2.26M
Novartis NOVN:VX 10.96B 826M
Spectrum Pharmaceuticals SPPI:US $ 14.06M 22.79M
Tg Therapeutics TGTX:US $ 95.27M 8.11M
Verastem VSTM:US $ 19.58M 4.73M
Ziopharm Oncology ZIOP:US $ 11.05M 11.64M